Interim / Quarterly Report • Sep 26, 2025
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
Unaudited Half-Yearly Financial Report 30 June 2025


Foresight Enterprise VCT plc is a Venture Capital Trust aiming to provide investors with regular dividends and capital growth from a portfolio of investments in fast‑growing, unquoted companies across the UK.

Payment of annual dividends of at least 5% of the NAV per share based on the opening NAV per share of that financial year

Growth in Net Asset Value Total Return above a 5% annual target while continuing to grow the Company's assets

Maintaining a programme of regular share buybacks at a discount of 5%, subject to market conditions

Implementation of a significant number of new and follow‑on investments, exceeding deployment requirements to maintain VCT status
| Annual results | |
|---|---|
| to 31 December 2025 | April 2026 |
| Annual General Meeting | June 2026 |
| Half-Yearly results | |
| to 30 June 2026 | September 2026 |






1 Foresight Enterprise VCT plc Unaudited Half-Yearly Financial Report 30 June 2025
27 Unaudited Half-Yearly Results and Responsibilities Statements
Hospital Services Group Limited was sold in the period, returning proceeds of £9.3 million to the Company at completion, including £0.5 million of accrued interest.
£162.1m
Total net assets as at 30 June 2025
£1.1m
Increase in valuation of investments in the period to 30 June 2025 3.1p Dividend paid 16 May 2025
51.6p NAV per share as at 30 June 2025
2 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
| Key metrics | Place of business | |||
|---|---|---|---|---|
| Six months to/ as at |
12 months to/ as at |
|||
| 30 June 2025 |
31 December 2024 |
|||
| Total net assets | £162.1m | £162.8m | ||
| Net Asset Value per share | 51.6p | 54.5p | ||
| Movement in Net Asset Value Total Return during the period1 | 0.4% | 6.6% | ||
| Share price | 48.8p | 50.5p | ||
| Dividend per share paid in the period | 3.1p | 15.4p | ||
| Dividend yield1 | 6.4% | 30.5% | ||
| Shares in issue | 314,372,565 | 298,828,254 |
| Six months to 30 June 2025 |
12 months to 31 December 2024 |
|
|---|---|---|
| Discount to NAV1 | 5.4% | 7.3% |
| Average discount on buybacks1 | 5.0% | 5.0% |
| Shares issued through fundraising | 17,703,296 | 49,802,894 |
| Shares issued under the dividend reinvestment scheme | 2,539,174 | 8,770,397 |
| Shares bought back during the period under review | 4,698,159 | 16,473,505 |
| Ongoing charges ratio (based on net assets)1, 2 | 2.35% | 2.34% |

Definitions of these Alternative Performance Measures ("APMs") can be found in the Glossary on page 35.
Capped at 2.35%. Special dividends paid during the period have been added back to period-end net assets and performance incentive fees have been added back to total expenses in the period. Expenses in the six-month period have been annualised.
3 Foresight Enterprise VCT plc Unaudited Half-Yearly Financial Report 30 June 2025

"I am pleased to present the unaudited Half-Yearly Financial Report for Foresight Enterprise VCT plc for the period ended 30 June 2025 and to report a Net Asset Value Total Return of 0.4% for the period, including a dividend yield of 6.4%."
Michael Gray Chair of Foresight Enterprise VCT plc The Company continues to perform well in the context of mixed wider economic conditions. The UK economy grew by 0.7% in the first quarter of 2025, however April and May saw two consecutive monthly contractions, leaving the overall growth in the period precariously flat. Inflation accelerated above the Bank of England's target, rising from around 3.0% in January to 3.4% in May and unexpectedly topping 3.8% in August, fuelled by higher food and clothing prices. While the Bank of England has continued to gradually reduce interest rates in the first eight months of 2025, this persistent inflation is likely to slow further cuts.
The combination of slow growth and increases on taxes, to the detriment of small businesses and the labour market, have created a challenging domestic economic landscape. This is not helped by the prospect of further tax rises in the autumn off the back of a series of U-turns by the Government on welfare reform. Internationally, the ongoing uncertainty over US tariffs and conflicts in Ukraine and the Middle East have also weighed on markets in the period. Against that backdrop, I am delighted to say our portfolio is performing well with some good exits and a positive pipeline of new investment opportunities being considered.
Portfolio overview

Investments as at 30 June 2025 £1.1m
Increase in valuation of investments in the period ended 30 June 2025
I believe the strong team of investment professionals at the Manager serves us well. The Manager's regional presence across core commercial centres in the UK further adds to the diversity of opportunities they can review and invest in. We will continue to have great focus to ensure the investee company and sector selections are considered, well researched and suggest good value prior to investment.
The Board believes that it is in the best interests of Shareholders to continue to pursue a strategy of:
Central to the Company being able to achieve these objectives is the ability of the Manager to source and complete attractive new qualifying investment opportunities and deliver strong exits.
£9.4m
Cash proceeds generated from disposal of investments and loan repayments in the period ended 30 June 2025
Unaudited Half-Yearly Financial Report 30 June 2025
During the period, Net Asset Value per share decreased by 5.3% from 54.5p as at 31 December 2024 to 51.6p as at 30 June 2025. After adding back a 3.1p dividend paid on 16 May 2025, NAV Total Return per share at 30 June 2025 was 54.7p, representing a positive NAV Total Return of 0.4% in the period.
On 1 November 2024, the Company launched an offer for subscription to raise up to £20 million, with an over‑allotment facility to raise up to a further £10 million, through the issue of new shares. The offer was closed on 10 April 2025 having raised gross proceeds of £30.0 million, £28.8 million after expenses. We would like to thank those existing Shareholders who have supported the offer and welcome all new Shareholders to the Company.
During the period, the Manager completed one new investment and six follow-on investments costing £1.5 million and £4.8 million respectively. The Manager successfully disposed of Hospital Services Group Limited, generating proceeds of £9.3 million, including £0.5 million of accrued interest, with potential for a further £0.4 million of deferred consideration over the coming years. Adding in the £0.9 million of cash returned in the investment period, this represents an exceptional return of 8.2 times the original investment. The Manager also exited a challenged business, Biotherapy Services Limited, for nil proceeds during the period. Further details of these investments and realisations can be found in the Manager's Review.
The Board and the Manager are confident that a number of new and follow-on investments can be achieved this year, particularly with the increased investment activity noted above. Details of each of these new, existing and former portfolio companies can be found in the Manager's Review.
The Manager continues to see a strong pipeline of potential investments sourced through its regional networks and well-developed relationships with advisers and the SME community; however, it is also focused on supporting the existing portfolio through the current economic climate.
The analysis of environmental, social and governance ("ESG") issues is embedded in the Manager's investment process and, whilst the Company has no specific objective to invest in companies which have an ESG focus, these factors are more generally considered key in determining the quality of a business and its long-term success. Central to the Manager's responsible investment approach are five ESG principles that are applied to evaluate investee companies, throughout the lifecycle of their investment, from their initial review and acquisition to their final sale. Every year, the portfolio companies are assessed and progress is measured against these principles. More detailed information about the process can be found on pages 24 and 25.
A special interim dividend of 3.1p per share was declared on 15 April 2025 based on an ex-dividend date of 1 May 2025 and a record date of 2 May 2025. The dividend was paid on 16 May 2025, returning £9.8 million to Shareholders. Additionally, an interim dividend of 2.8p per share was declared on 24 June 2025 based on an ex-dividend date of 3 July 2025 and a record date of 4 July 2025. The dividend was paid post period end on 18 July 2025, returning £8.8 million to Shareholders.
The Board and the Manager continue to hope that additional special dividends can be paid as and when particularly successful portfolio exits are made.
The Board is pleased to have achieved an average discount across all buybacks of 5.0% to the Net Asset Value per share in the period and continues to have an objective of maintaining buybacks at a discount of 5.0%, subject to market conditions.
5 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
We were delighted to hold the AGM on 10 June 2025. We hope many of you will be available to attend our next in‑person investor forum event which will be announced in due course. These events have proven very popular with our Shareholders in the past and provide the opportunity to learn first-hand about some of our investee companies from their founders and management.
The Board continues to review its own performance and undertakes succession planning to maintain an appropriate level of independence, experience, diversity and skills in order to be in a position to discharge all its responsibilities.
As I mentioned in my introduction, the business environment is challenging with slow growth, persistent inflation and a hostile geopolitical landscape. We are therefore carefully considering how all of these factors, in an ever-changing world, test the investment thesis.
We do, however, have the benefit of these developing companies in which we invest on the whole being able to more swiftly adapt to the fast-moving environment in which we operate, with the benefit of our Manager's experience and a strong funding base.
We have a diverse portfolio of investments and we are confident that our continued focus on the wider business landscape, alongside the Manager's deep understanding of the individual investee companies in which we invest, will protect us from the most extreme market conditions.

26 September 2025
6 Foresight Enterprise VCT plc Unaudited Half-Yearly Financial Report 30 June 2025
7 Foresight Enterprise VCT plc Unaudited Half-Yearly Financial Report 30 June 2025

James Livingston on behalf of Foresight Group LLP Co-Head of Private Equity
The Board has appointed Foresight Group LLP (the "Manager") to provide investment management and administration services.
As at 30 June 2025, the Company's portfolio comprised 45 investments with a total cost of £79.5 million and a valuation of £107.7 million. The portfolio is diversified by sector, transaction type and maturity profile. Details of the ten largest investments by valuation, including an update on their performance, are provided on pages 17 to 20.
During the six months to 30 June 2025, the value of the investment portfolio decreased by £1.5 million largely as a result of a successful realisation and a loan repayment, generating £8.9 million, exclusive of £0.5 million accrued interest paid on the realisation. This was partially offset by an increase of £1.1 million in the valuation of the remaining investments, plus £6.3 million of new and follow‑on investments.

Overall, the portfolio has performed well despite uncertainty in the market with continually looming US tariffs, ongoing global conflicts and persistent domestic price inflation.
In line with the Board's strategic objectives, we remain focused on growing the Company through further development of Net Asset Value Total Return. For the six months to 30 June 2025, Net Asset Value Total Return was 0.4% and net assets marginally decreased by 0.4% to £162.1 million, following the payment of a dividend of 3.1p per share and returning £9.8 million to Shareholders.
Unaudited Half-Yearly Financial Report 30 June 2025
One new investment of £1.5 million was completed in the six months to 30 June 2025. Follow-on investments totalling £4.8 million were also made into six existing investee companies. There is a strong pipeline of opportunities that we expect to convert during the second half of 2025.
The Company made follow-on investments in six companies during the six months to 30 June 2025, totalling £4.8 million. Further details of each of these are provided opposite and on the following page.
The additional equity injections in the period were used to support further growth plans, such as launching new products and expansion of commercial capabilities. We continue to successfully navigate the volatility that has been felt across the markets over the course of the year and remain vigilant about the health of the portfolio and the need for follow-on funding during the second half of 2025. Given the size of the portfolio, further opportunities to deploy capital into growing existing investments are expected.
In March 2025, the Company completed a £1.5 million investment into Ad Signal Limited, a provider of digital content management software for the media and entertainment industry. The company's founder has strong technical skills and significant experience in developing content management solutions. The investment will enable the company to develop further tools to support its customers and add further blue-chip clients. To support these growth ambitions, the Manager invited Tom Toumazis MBE to join the team as Non-Executive Chair. Tom brings a wealth of experience in the media and entertainment industry, as well as being involved with several early-stage technology businesses.

9 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025

In February 2025, the Company completed a £1.5 million follow-on investment into Loopr Ltd (trading as "Looper Insights"), a company providing data analytics to content distributors and video-on-demand streaming services. The investment will support the company's next phase of product development, the growth of the sales and business development teams and continue the rollout to new and existing customers internationally, including regulators, multinationals and local media outlets.
In March 2025, the Company completed a £0.6 million follow-on investment into Evolve Dynamics Limited ("Evolve"). The investment will support the company's working capital and research and development initiatives as the business continues to target both private and public sector contracts. Evolve develops and manufactures Unmanned Aircraft Systems and, since investment, it has developed and begun to commercialise two new systems.
In April 2025, the Company completed a £0.2 million investment into NorthWest EHealth ("NWEH"). This was followed by a further £0.3 million in May 2025. NWEH is a provider of technology‑enabled clinical trials services to the pharmaceutical and life sciences sectors, leveraging NHS electronic health records. The investments during the year will enable NWEH further cash runway to convert an important commercial opportunity, which has since commenced.

In March 2025, the Company completed a £0.7 million follow-on investment into Fourth Wall Creative. Fourth Wall Creative provides fan engagement services to Premier League and Championship football clubs and other sporting organisations via its technology platforms. It also designs, sources and fulfils membership welcome packs and related products. The investment will support the continued growth and development of the business.

In March 2025, the Company completed a £0.6 million follow-on investment into Ten Health, alongside a £0.2 million co-investment from senior management. This funding will primarily be used to launch a new franchise model to generate scale at pace and enable Ten Health to open a presence in locations across the UK, specifically beyond London, and internationally.

In May 2025, the Company completed a £0.9 million follow‑on investment into HomeLink Healthcare. The Company first invested into HomeLink in March 2022 and completed a follow-on investment in March 2024. Contracting with the NHS and private hospitals, the business provides patients with wound care, physiotherapy and intravenous therapies in their own home. HomeLink is also a leader in remote patient monitoring practices, offers a virtual ward solution and has now saved the NHS over 150,000 hospital bed days. The investment will support the organic expansion of the company.
10 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
After the period end, the Company completed three follow‑on investments totalling £0.6 million into Sprintroom Limited, which designs and manufactures drives for controlling electric motors, Kognitiv Spark Inc, a developer of augmented reality software, and Strategic Software Applications Ltd, a London-based SaaS technology provider supporting financial institutions in meeting their regulatory compliance obligations. The Company also completed two new investments totalling £3.0 million into Aircards Limited, a Newcastle-based specialist marketing agency focusing on the augmented reality sector, and MyWay Digital Health Limited, a digital self‑management platform for people with diabetes. The Company exited its holding of Vio Healthtech Limited, which has been held at nil value since December 2022, for no proceeds. This exit will preserve staff roles and allow the company to continue trading and utilising its technology for the benefit of women's health.
The M&A climate has proven more challenging in recent years in light of macroeconomic conditions, including higher interest rates and geopolitical uncertainty alluded to above. Despite this, we are pleased to report the particularly strong realisation of Hospital Services Group Limited, as well as the disposal of Biotherapy Services Limited, a challenged business within the portfolio. We continue to engage with a range of potential acquirers of several portfolio companies and to carefully consider the timing of exit for each. Demand from both private equity and trade buyers remains for high‑quality, high‑growth businesses.

In January 2025, the Company completed its sale of Hospital Services Group Limited ("HSL"), a provider of high-quality healthcare equipment and consumables. The transaction generated proceeds of £8.8 million at completion and £0.9 million in interest over the life of the investment, with potential for a further £0.4 million of deferred consideration over the coming years. This implies a return and IRR of 8.2 times the original investment and 25.6% respectively. HSL provides equipment to a growing number of customers on both sides of the Irish Sea, with over 500 medical facilities supported in 2024. Since investment, HSL has seen strong organic growth and has made eight strategic bolt-on acquisitions, most notably in Ireland. The exit is reflective of Foresight's commitment to supporting sustainable growth, as well as its continued success in the Healthcare sector.

In March 2025, the Company exited its holding in Biotherapy Services Limited ("BTS") for a nominal value to management. Despite promising early clinical results, BTS struggled to complete its Phase IIB trial of its RAPID gel product within its funding runway. The trial was significantly hampered by COVID-19, with diabetic trial participants needing to shield. BTS has recently published its data and analysis. If the business is sold in the medium term, the Company will receive deferred consideration. BTS was fully written off in December 2022.

11 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
| Exit proceeds | |||||
|---|---|---|---|---|---|
| Accounting | excluding | Valuation at | |||
| cost at date | deferred | Realised | 31 December | ||
| of disposal | consideration2 | gain/(loss) | 2024 | ||
| Company | Detail | (£) | (£) | (£) | (£) |
| Hospital Services Group Limited1 | Full disposal | 1,200,000 | 8,787,773 | 7,587,773 | 9,272,696 |
| Biotherapy Services Limited | Full disposal | 2,250,000 | — | (2,250,000) | — |
| Positive Response Corporation Ltd | Loan repayment | 100,000 | 100,000 | — | 100,000 |
| 3,550,000 | 8,887,773 | 5,337,773 | 9,372,696 |
Excludes up to £0.4 million of deferred consideration.
Proceeds on exit excluding interest, dividends and exit fees where applicable.
As at 30 June 2025, the Company had cash reserves of £52.6 million, which will be used to fund new and follow‑on investments, buybacks, dividends and corporate expenditure. We are seeing a strong pipeline of new opportunities, with several opportunities in due diligence or in exclusivity, with further deal completions expected to be announced in the months to follow.
The global economic and geopolitical environment remains volatile and uncertain, in the face of a tariff war instigated by the US and actual wars being fought both in Europe and the Middle East. Markets are showing strong resilience in the face of these challenges however, with many indices performing well in the year to date overall.
Against this unsettled backdrop, the UK economy is performing reasonably well, with interest rates falling and a trade deal of sorts with the US supporting a strong performance in the FTSE.
With a broad network of deal introducers across the UK and internationally, and through its growing network of regional offices, we continue to see a large volume of attractive investment opportunities. This is not expected to change in the medium term. We continue to pursue a balanced strategy, targeting companies from a range of sectors and at different stages of maturity to combat market volatility.

12 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
Material changes in valuation, defined as increasing or decreasing by £1.0 million or more since 31 December 2024, are detailed below. Updates on these companies are included opposite or in the Top Ten Investments section on pages 17 to 20.
| Company | Valuation methodology |
Net movement (£) |
|---|---|---|
| Hexarad Group Limited1 | Discounted revenue multiple |
1,601,045 |
| NorthWest EHealth Limited1 | Discounted revenue multiple |
1,079,130 |
| Rovco Limited | Nil value | (2,033,874) |
Rovco, trading as Beam, was established in 2015 by CEO Brian Allen as a provider of subsea infrastructure surveying services, primarily for offshore wind.
Despite positive interest from investors in a large growth funding round at the beginning of 2025, this failed to materialise, leaving the company insolvent. As such, after thoroughly exploring all options, the directors resolved to put the company into administration at the end of April.

13 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
2025 has so far been another year characterised by volatility, largely driven by a global tariff war instigated by the US. Prior to this, markets were showing some signs of recovery and stability. While many indexes have rebounded relatively quickly from the initial shock of increased tariffs from the US, the impacts of this are yet to be really felt and may cause further volatility over the coming months and years. The sense of uncertainty is also reflected in the geopolitical environment, with new and old conflicts persisting and a seeming polarisation of politics across the globe.
Against this uncertain backdrop, the Company has performed well in the year to date. NAV Total Return in the year to date is 0.4%. The strong exit from Hospital Services Group Limited has significantly contributed to the dividend of 3.1p paid in May, with an attractive dividend yield of 6.4%. The Company maintains a balanced portfolio across different sectors and stages of the business lifecycle, which should stand it in good stead to face the volatility ahead. Our hands-on approach to challenges and exit planning continues to add value to portfolio companies.
Looking to the remainder of 2025 and beyond, it would be reasonable to expect further volatility given the geopolitical and economic environment. However, lower tariffs and falling interest rates, combined with the US's stated policy of isolationism, should make the UK an attractive place to set up and do business. London remains a crucial financial sector, and early signs indicate potentially improved interest in London initial public market offerings.
We are pleased with the performance in the year to date. The Company has completed another highly successful fundraise, thanks to the strong track record delivered over a number of years. The Company continues to deploy into high potential new investments, and a growing portfolio of assets at varying stages of the lifecycle, with a strong pipeline of further opportunities also building. There has been a very attractive exit in the period. The portfolio remains diversified across sectors, with a mix of higher-growth and cash‑generative businesses and has proven to be resilient over many years and through various cycles and economic shocks. The Company remains one of the premier players in the VCT market, an important source of capital for UK entrepreneurs.
26 September 2025
14 Foresight Enterprise VCT plc Unaudited Half-Yearly Financial Report 30 June 2025
Founded in Cheddar in 2019, Family Adventures Group Ltd ("FAGL") is a provider of daycare nurseries and children's leisure sites. The leisure sites are specifically differentiated soft play centres that utilise digitalisation, gamification and are further enhanced by role play zones. FAGL operates across the South West, South Wales and the Midlands, with plans to expand along the M4 and M5 corridors.
Since investment, the company has expanded from five to 14 day nurseries and has opened a third leisure site. Growth has been both organic and acquisitive. FAGL has launched four new nurseries in the Midlands and South West and purchased Green Giraffe Day Nursery in 2025.
As the expansion of funding for early years education continues, with all children over nine months in England now eligible for 15-30 hours of childcare per week, FAGL is currently focusing on expanding its nursery business by opening new sites and acquiring small groups. The Manager has strengthened the team by hiring a Finance Director, a Head of Quality and an experienced Chair.
FAGL has received numerous local and national awards. Most notably, the company was recently listed in the Times 100 Companies to Work For and was included in the Day Nurseries Top 20 Mid-Size Nursery Groups.

investment made by Foresight Enterprise VCT plc, £2.5 million by Foresight VCT plc and £5.3 million by other Foresight funds)
Key insights

£2.5m Foresight Enterprise VCT plc commitment Jan 2024 Initial investment date Income Stage
15 Foresight Enterprise VCT plc Unaudited Half-Yearly Financial Report 30 June 2025
HomeLink Healthcare ("HomeLink") provides "Hospital at Home" services. The company employs nurses on a full-time basis and contracts with hospitals to provide services including wound care, physiotherapy and intravenous therapies to patients in their own home. HomeLink has also expanded into the remote monitoring sector and offers a virtual ward solution.
HomeLink works with both the NHS and private hospitals to provide services to patients outside of hospital settings. The company has recently signed up its first private hospital in The London Clinic and has expanded its treatment pathways to include oncology. HomeLink benefits from NHS policy tailwinds, where Lord Darzi's independent report on the state of the NHS in England and the NHS 10 Year Health Plan have focused on the key pillars of digitalisation, prevention not cure, and a return to community care.
A key growth focus will be reablement contracts, which expedite discharge from hospital for patients and reduce the bed-blocking epidemic in the NHS. Additional growth avenues include expansion into more treatment pathways including dialysis and diabetes care. The company is well positioned for growth within the NHS procurement process.
| Location | Mimet House, 5a Praed Street, London W2 1NJ |
|---|---|
| Website | www.homelinkhealthcare.co.uk |
| Total Foresight Group | £5.9 million (£3.0 million by |
| LLP commitment | Foresight Enterprise VCT plc and £2.9 million by Foresight VCT plc) |
Growth
Stage
Key insights

£3.0m Foresight Enterprise VCT plc commitment
Mar 2022 Initial investment date Introduction Strategic Report Governance Financial Statements
16 Foresight Enterprise VCT plc Unaudited Half-Yearly Financial Report 30 June 2025
31 March 2025
The Manager is a leading private equity investment manager, with its parent, Foresight Group Holdings Limited, listed on the London Stock Exchange. Foresight invests in building cleaner energy systems, decarbonising industry and growing the economic potential of ambitious companies.


| Key | ||
|---|---|---|
| Infrastructure 77% |
||
| Private Equity 14% |
||
| Foresight Capital Management | 9% |
Foresight's Private Equity division is one of the most active UK & Ireland regional SME investors, supporting companies through various economic cycles.
Foresight partners with promising SMEs across all sectors and deal stages. Each year it reviews over 3,000 business plans and currently supports more than 250 SMEs.
On 9 February 2021, Foresight Group Holdings Limited's shares were unconditionally listed on the premium segment of the Official List maintained by the Financial Conduct Authority (the "FCA") (the "Official List") and admitted to trading on the Main Market of the London Stock Exchange under the ticker "FSG". Since the FCA's new UK Listing Rules came into force on 29 July 2024, Foresight Group Holdings Limited has been automatically transferred to the Equity Shares (Commercial Companies) category on the Official List. Foresight Group Holdings Limited was awarded the LSE's Green Economy Mark, which recognises companies that derive 50% or more of their annual revenues from products and services that contribute to the global green economy.
17 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
For the investments below held by Foresight 3 VCT plc ("F3") pre-merger on 22 June 2017, the amount invested refers to the initial amount invested by F3 and the Company. The accounting cost includes both the initial investment by both funds and also the valuation of the F3 investment at the point it was transferred to the Company.
| Location | London |
|---|---|
| Website | www.hexarad.com |
| Hexarad is a teleradiology company, supporting NHS and |
|---|
| private healthcare providers with access to a diversified pool of |
| radiologists to provide fast, accurate diagnoses and enable more |
timely and higher-quality patient care.
Hexarad has grown strongly in the current period, with incremental revenue from existing and new NHS Trust customers. The NHS continues to experience long waiting lists, with fast and accurate diagnosis a key step in addressing this priority. AI and broader technology development are key themes within radiology and represent core aspects of Hexarad's product strategy.
| Hexarad Group Limited | TLS HoldCo Limited | Professionals At Play Ltd | |||
|---|---|---|---|---|---|
| Location London |
Location | Leicestershire | |||
| Website www.hexarad.com |
Website | www.truelens.co.uk | |||
| Sector Healthcare |
Sector | Other |
True Lens Services is a specialist provider of lens manufacturing, refurbishment and servicing to the film and television markets.
Sales and EBITDA are behind the same period in the prior year. This is reflective of an exceptional performance in the prior year as the company took advantage of improvements made previously in recruitment, productivity and a larger premises to reduce lead times. A focus in the last six months for True Lens Services has been on new product development and increasing sales and marketing to open new markets. These initiatives will help deliver future growth.
| Initial investment date | June 2021 |
|---|---|
| Amount invested (£) | 2,300,034 |
| Accounting cost (£) | 2,300,034 |
| Valuation (£) | 7,957,316 |
| Basis of valuation | Discounted revenue multiple |
| Equity held (%) | 11.2% |
| Initial investment date | December 2015 |
|---|---|
| Amount invested (£) | 100 |
| Accounting cost (£) | 100 |
| Valuation (£) | 7,325,394 |
| Basis of valuation | Net assets |
| Equity held (%) | 42.5% |
| Location | Manchester | ||||
|---|---|---|---|---|---|
| Website | www.professionalsatplay.co.uk | ||||
| Sector | Consumer & Leisure |
Professionals At Play (formerly known as Roxy Leisure) is a games bar group with venues across the UK. It offers a range of entertainment facilities including pool tables, ping-pong, bowling, shuffleboard, mini golf, arcade games and karaoke.
Professionals At Play continues to grow as it delivers on its focused growth strategy by expanding its site footprint into new geographical locations. In the six months to 30 June 2025, the business has launched new sites under its Roxy Ballroom brand in London and under its King Pins brand in Bristol and Glasgow, with London quickly scaling to become one of the top-performing sites. There is a strong pipeline of new site openings over the remainder of 2025 and into 2026. Economic pressures remain, with consumer spend headwinds being evident in the industry data. This is impacting the established estate with like‑for‑like sales decline tracking the industry averages, although the business remains significantly profitable.
| Initial investment date | December 2019 | |
|---|---|---|
| Amount invested (£) | 2,500,000 | |
| Accounting cost (£) | 2,500,000 | |
| Valuation (£) | 6,117,339 | |
| Basis of valuation | Discounted earnings multiple | |
| Equity held (%) | 5.6% |
Unaudited Half-Yearly Financial Report 30 June 2025
By value as at 30 June 2025

| Location | Manchester |
|---|---|
| Website | www.nweh.co.uk |
| Sector | Healthcare |
NorthWest EHealth ("NWEH") provides software and services to the clinical trial market for the design, recruitment, feasibility analysis and delivery of clinical trials.
NWEH has made significant progress over the period with a large potential client, which launched a new large trial supported by NWEH post period end. With a focus on growing the sales pipeline, a Head of Sales was recruited in early July and further investment in the commercial organisation is likely to take place later in the year. As part of this, the Company supported NWEH with two follow‑on rounds over the period.
| NorthWest EHealth Limited |
Spektrix Limited | Fourth Wall Creative Limited | |
|---|---|---|---|
| Location Manchester |
Location | London | |
| Website www.nweh.co.uk |
Website | www.spektrix.com | |
| Sector Healthcare |
Sector | Technology, Media & Telecommunications |
Spektrix is an enterprise software company, providing ticketing, customer relationship management, marketing and fundraising software in the performing arts sector across the UK and the US.
Spektrix continued to perform well in the six-month period to 30 June 2025, driven by strong ticket sales across the UK and Ireland as well as the US and Canada. Integration of its first bolt-on acquisition in Canada has been successful, with positive feedback received, and the company continues to onboard the target's customers onto its platform. As part of its ongoing geographical expansion, Spektrix has recruited its first team members in Sydney and has won its first Australian client.
| <TRIXKK |
|---|
| --------- |
| Creative Limited | |
|---|---|
| Location | Wirral |
|---|---|
| Website | www.fourthwallcreative.com |
| Sector | Business Services |
Fourth Wall Creative provides fan engagement services to Premier League and Championship football clubs and other sporting organisations via its technology platforms. It also designs, sources and fulfils membership welcome packs and related products.
Revenue remains in line with that of the comparable period in the prior year, during its typically low seasonal period. The business remains focused on delivering on its FY25 revenue and EBITDA targets, with a large amount of revenue and EBITDA to be delivered in the second half of 2025, which will be subject to the customers confirming orders in time to allow for logistics and products to be delivered from the Far East.
| Initial investment date | June 2021 |
|---|---|
| Amount invested (£) | 5,999,999 |
| Accounting cost (£) | 5,999,999 |
| Valuation (£) | 5,532,473 |
| Basis of valuation | Discounted revenue multiple |
| Equity held (%) | 38.5% |
| Initial investment date | December 2018 |
|---|---|
| Amount invested (£) | 2,998,350 |
| Accounting cost (£) | 2,267,477 |
| Valuation (£) | 4,919,988 |
| Basis of valuation Discounted revenue multiple |
|
| Equity held (%) | 5.0% |
| Initial investment date | April 2019 |
|---|---|
| Amount invested (£) | 3,600,000 |
| Accounting cost (£) 3,600,000 |
|
| Valuation (£) | 4,786,673 |
| Basis of valuation | Discounted revenue multiple |
| Equity held (%) | 16.1% |
Unaudited Half-Yearly Financial Report 30 June 2025
| Red Flag Alert Technology Group Limited | Strategic Software Applications Ltd | Loopr Ltd | ||
|---|---|---|---|---|
| Location | Manchester | Location | London | |
| Website | www.redflagalert.com | Website | www.ruleguard.com | |
| Sector | Technology, Media & Telecommunications | Sector | Business Services |
Red Flag Alert is a business intelligence platform with modular capabilities spanning compliance, prospecting, risk management and financial health assessments, which is sold into a growing corporate customer base.
Red Flag Alert continues to grow strongly with ARR having more than doubled since investment, reaching £4.9 million as at 30 June 2025. The company is targeting more enterprise level customers in four key sectors and continues to invest in the technology to support the change in go-to-market strategy, which is already yielding results.
Trading as Ruleguard, Strategic Software Applications Ltd is a SaaS regulatory compliance platform for financial services institutions.
Ruleguard has continued a steady growth trajectory over the period by signing several client deals with large well-known financial institutions. Market demand for Ruleguard's product offering remains high and there are growing levels of inbound enquiries from international businesses. To help support the growth trajectory, an experienced Finance Director was recruited in the spring, and an experienced Head of Sales with extensive software sales experience joined Ruleguard in July.


| Location | London |
|---|---|
| Website | www.looperinsights.com |
| Sector | Technology, Media & Telecommunications |
Loopr Ltd (trading as "Looper Insights") is a company providing data analytics to content distributors and video-on-demand streaming services.
Looper Insights continues to grow steadily by adding new customers and expanding existing contracts. Market demand remains high as studios and video-on-demand platforms seek improved returns on investment from their content spend. Like-for‑like competition remains limited, enabling the company to secure large contracts with industry-leading customers on favourable terms. A follow-on funding round completed during the quarter, which included funding from new angel investors.
| Initial investment date | March 2023 |
|---|---|
| Amount invested (£) | 2,775,000 |
| Accounting cost (£) | 2,775,000 |
| Valuation (£) | 4,088,667 |
| Basis of valuation | Price of last funding round |
| Equity held (%) | 15.0% |
| Initial investment date | August 2022 |
|---|---|
| Amount invested (£) | 2,749,994 |
| Accounting cost (£) | 2,749,994 |
| Valuation (£) | 4,083,558 |
| Basis of valuation | Discounted revenue multiple |
| Equity held (%) | 17.6% |
| Initial investment date | September 2023 | |
|---|---|---|
| Amount invested (£) | 3,250,001 | |
| Accounting cost (£) | 3,250,001 | |
| Valuation (£) | 3,825,425 | |
| Basis of valuation | Price of last funding round | |
| Equity held (%) | 9.9% |
20 Foresight Enterprise VCT plc Docusign Envelope ID: 3BD61028-06D2-4CA5-8A1C-CDF578A863FA
Unaudited Half-Yearly Financial Report 30 June 2025
Top Ten Investments By value as at 30 June 2025
| PH Realisations 2020 Limited | |
|---|---|
| Location | Leicestershire |
| Website | www.truelens.co.uk |
| Sector | Other |
PH Realisations 2020 Limited holds part of the Company's investment in True Lens Services, which is a specialist provider of lens manufacturing, refurbishment and servicing to the film and television markets.
Sales and EBITDA are behind the same period in the prior year. This is reflective of an exceptional performance in the prior year as the company took advantage of improvements made previously in recruitment, productivity and a larger premises to reduce lead times. A focus in the last six months for True Lens Services has been on new product development and increasing sales and marketing to open up new markets. These initiatives will help deliver future growth.
| Initial investment date | April 2013 |
|---|---|
| Amount invested (£) | 1,524,993 |
| Accounting cost (£) | 2,162,929 |
| Valuation (£) | 3,446,497 |
| Basis of valuation | Discounted earnings multiple |
| Equity held (%) | 42.5% |

Unaudited Half-Yearly Financial Report 30 June 2025
| 30 June 2025 | 31 December 2024 | ||||
|---|---|---|---|---|---|
| Accounting cost | Valuation | Accounting cost | Valuation | ||
| Investment by value | £ | £ | Valuation methodology | £ | £ |
| Hexarad Group Limited1 1. |
2,300,034 | 7,957,316 | Discounted revenue multiple | 2,300,034 | 6,356,271 |
| TLS HoldCo Limited1 2. |
100 | 7,325,394 | Net assets | 100 | 7,983,256 |
| Professionals At Play Ltd1 3. |
2,500,000 | 6,117,339 | Discounted earnings multiple | 2,500,000 | 6,237,306 |
| NorthWest EHealth Limited1 4. |
5,999,999 | 5,532,473 | Discounted revenue multiple | 5,499,999 | 3,953,343 |
| Spektrix Limited1 5. |
2,267,477 | 4,919,988 | Discounted revenue multiple | 2,267,477 | 4,966,190 |
| Fourth Wall Creative Limited1 6. |
3,600,000 | 4,786,673 | Discounted revenue multiple | 2,900,000 | 4,791,852 |
| Red Flag Alert Technology Group Limited1 7. |
2,775,000 | 4,088,667 | Price of last funding round | 2,775,000 | 4,044,092 |
| Strategic Software Applications Ltd1 8. |
2,749,994 | 4,083,558 | Discounted revenue multiple | 2,749,994 | 3,572,684 |
| Loopr Ltd1 9. |
3,250,001 | 3,825,425 | Price of last funding round | 1,750,000 | 2,122,732 |
| PH Realisations 2020 Limited1 10. |
2,162,929 | 3,446,497 | Discounted earnings multiple | 2,162,929 | 3,446,497 |
| Clubspark Group Ltd 11. |
2,460,000 | 3,421,073 | Discounted revenue multiple | 2,460,000 | 3,430,322 |
| HomeLink Healthcare Limited 12. |
2,956,983 | 3,379,619 | Price of last funding round | 2,075,047 | 2,938,219 |
| Ten Health & Fitness Limited 13. |
3,000,000 | 3,271,159 | Discounted revenue multiple | 2,400,000 | 3,142,076 |
| Biofortuna Limited 14. |
3,517,537 | 3,262,000 | Discounted revenue multiple | 3,517,537 | 3,162,360 |
| Mizaic Ltd 15. |
2,400,000 | 3,219,808 | Discounted revenue multiple | 2,400,000 | 2,385,344 |
| Titania Group Limited 16. |
1,250,000 | 3,212,976 | Discounted revenue multiple | 1,250,000 | 2,860,695 |
| Family Adventures Group Ltd 17. |
2,500,000 | 2,785,242 | Price of last funding round | 2,500,000 | 2,500,000 |
| Evolve Dynamics Limited 18. |
2,624,999 | 2,625,185 | Price of last funding round | 1,999,999 | 1,999,999 |
| I-Mist Group Limited 19. |
1,614,500 | 2,267,247 | Discounted earnings multiple | 1,614,500 | 2,045,350 |
Unaudited Half-Yearly Financial Report 30 June 2025
| 30 June 2025 | 31 December 2024 | |||||
|---|---|---|---|---|---|---|
| Investment by value | Accounting cost £ |
Valuation £ |
Valuation methodology | Accounting cost £ |
Valuation £ |
|
| Firefish Software Ltd. 20. |
1,500,000 | 2,191,334 | Discounted revenue multiple | 1,500,000 | 2,129,776 | |
| Resi Design Limited 21. |
1,950,000 | 1,950,000 | Cost | 1,950,000 | 1,950,000 | |
| Lepide Group Holding Company Ltd 22. |
1,958,916 | 1,888,779 | Discounted revenue multiple | 1,958,916 | 1,958,916 | |
| Navitas Group Limited 23. |
1,500,000 | 1,860,356 | Discounted revenue multiple | 1,500,000 | 1,717,868 | |
| Positive Response Corporation Ltd 24. |
459,195 | 1,757,520 | Discounted revenue multiple | 559,195 | 1,863,724 | |
| Sprintroom Limited 25. |
1,760,000 | 1,631,234 | Discounted earnings multiple | 1,760,000 | 1,345,698 | |
| Steamforged Holdings Limited 26. |
1,600,000 | 1,629,717 | Discounted revenue multiple | 1,600,000 | 1,476,316 | |
| Five Wealth Limited 27. |
712,500 | 1,611,277 | % of AUM | 712,500 | 1,266,541 | |
| Itad (2015) Limited 28. |
1,371,726 | 1,609,530 | Discounted earnings multiple | 1,371,726 | 2,120,887 | |
| Ad Signal Limited 29. |
1,499,998 | 1,499,998 | Cost | — | — | |
| Live Group Holdings Limited 30. |
1,400,002 | 1,407,180 | Discounted revenue multiple | 1,400,002 | 882,173 | |
| ABL Investments Limited 31. |
1,494,075 | 1,323,505 | Discounted earnings multiple | 1,494,075 | 1,134,888 | |
| Copptech UK Limited 32. |
2,455,000 | 1,301,730 | Discounted revenue multiple | 2,455,000 | 1,598,396 | |
| Iphigenie Limited 33. |
100 | 1,288,381 | Net assets | 100 | 1,277,816 | |
| Newsflare Limited 34. |
2,000,000 | 1,156,646 | Discounted revenue multiple | 2,000,000 | 1,032,698 | |
| Aerospace Tooling Corporation Limited 35. |
415,255 | 1,072,140 | Discounted revenue multiple | 415,255 | 636,459 | |
| Kognitiv Spark Inc 36. |
1,000,000 | 1,000,000 | VC method | 1,000,000 | 928,750 | |
| Whitchurch PE 1 Limited 37. |
378,000 | 624,190 | Net assets | 378,000 | 631,443 | |
| Weduc Holdings Limited 38. |
302,941 | 484,338 | Discounted revenue multiple | 302,941 | 531,568 |
Unaudited Half-Yearly Financial Report 30 June 2025
| 30 June 2025 | 31 December 2024 | |||||
|---|---|---|---|---|---|---|
| Investment by value | Accounting cost £ |
Valuation £ |
Valuation methodology | Accounting cost £ |
Valuation £ |
|
| Cole Henry PE 2 Limited 39. |
200,000 | 348,215 | Net assets | 200,000 | 355,467 | |
| 40. The KSL Clinic Limited | 1,000,000 | 318,925 | Discounted earnings multiple | 1,000,000 | 295,608 | |
| 41. Kingsclere PE 3 Limited | 100,000 | 194,780 | Net assets | 100,000 | 202,066 | |
| 42. Additive Manufacturing Technologies Ltd | 1,833,018 | — | Discounted revenue multiple | 1,833,018 | 528,093 | |
| 43. Rovco Limited | 1,476,880 | — | Nil value | 1,476,880 | 2,033,874 | |
| 44. Sindicatum Carbon Capital Limited | 544,538 | — | Nil value | 544,538 | — | |
| 45. Vio Healthtech Limited | 689,928 | — | Nil value | 689,928 | — | |
| 46. Biotherapy Services Limited | — | — | Sold | 2,250,000 | — | |
| 47. Hospital Services Group Limited | — | — | Sold | 1,200,000 | 9,272,696 | |
| Total | 79,531,625 | 107,677,414 | 76,774,690 | 109,110,309 |
Unaudited Half-Yearly Financial Report 30 June 2025
Often referred to as Responsible Investment, environmental, social and governance principles ("ESG") provide not only a key basis for generating attractive returns for investors, but also to help build better-quality businesses in the UK, creating jobs and making a positive contribution to society.
ESG criteria form an integral part of the Manager's day‑to‑day decision making, with all new investments made since May 2018 subject to ESG due diligence and ongoing ESG monitoring.
This accounts for c.73% of the current portfolio, with the view to reaching 100% as legacy investments are sold over time. Central to its investment approach are five ESG principles which are used to evaluate investee companies.
Overall, 100 individual key performance indicators are considered under the five principles.
The Manager invests in a wide range of sectors and believes its approach covers the key tests that should be applied to assess a company's ESG performance, throughout the life cycle of an investment:

Does the business demonstrate a good awareness of corporate social responsibility?
Is this reflected in its processes and management structure?

Does the company follow good practice for limiting or mitigating its environmental impact, in the context of its industry?
How does it encourage the responsible use of the world's resources?

What impact does the company have on its employees, customers and society as a whole?
Is it taking steps to improve the lives of others, either directly, such as through job creation, or indirectly?

Does the company and its leadership team demonstrate integrity?
Are the correct policies and structures in place to ensure it meets its legislative and regulatory requirements?

Is the principle of corporate responsibility evidenced in the company's supply chain and customers?
How does it promote ESG values and share best practice?
25 Foresight Enterprise VCT plc Unaudited Half-Yearly Financial Report 30 June 2025
The UN's Sustainable Development Goals ("SDGs") also represent an important lens through which corporate and investment activities are reviewed.
In May 2021, the Manager formalised its Investment Themes for private equity investments into four areas:
Quality Employment at Scale
Sustainable, Inclusive, Local Infrastructure and the Environment
These outcome-focused themes help the Manager assess any opportunities in the business model, and by mapping its investments to them, the private equity team can identify the value and benefits for the companies, society and the environment.
Each portfolio company is subject to an annual assessment where progress against each of the five principles is measured and an evaluation matrix is updated to allow progress to be tracked and continuous improvement encouraged.
Introduction Strategic Report Governance Financial Statements

26 Foresight Enterprise VCT plc Unaudited Half-Yearly Financial Report 30 June 2025
27 Unaudited Half-Yearly Results and Responsibilities Statements
Unaudited Half-Yearly Financial Report 30 June 2025
The principal risks faced by the Company are as follows:
The Board reported on the principal risks and uncertainties faced by the Company in the Annual Report and Accounts for the year ended 31 December 2024. A detailed explanation can be found on pages 47 to 50 of the Annual Report and Accounts, which is available on Foresight Enterprise VCT's website www.foresightenterprisevct.com or by writing to Foresight Group LLP at The Shard, 32 London Bridge Street, London SE1 9SG.
In the view of the Board, there have been no changes to the fundamental nature of these risks since the previous Annual Report and Accounts. The emerging risks identified in the previous report included those of geopolitical risk, cyber security, artificial intelligence, potential economic instability and the risk of a global pandemic. These emerging risks continue to apply and be monitored. The Board and the Manager continue to follow all emerging risks closely with a view to identifying where changes affect the areas of the market in which portfolio companies operate. This enables the Manager to work closely with portfolio companies, preparing them so far as possible to ensure they are well positioned to endure potential volatility.
The Disclosure and Transparency Rules ("DTR") of the UK Listing Authority require the Directors to confirm their responsibilities in relation to the preparation and publication of the Half-Yearly Financial Report.
The Directors confirm to the best of their knowledge that:
The Company's business activities, together with the factors likely to affect its future development, performance and position, are set out in the Strategic Report of the Annual Report. The financial position of the Company, its cash flows, liquidity position and borrowing facilities are described in the Chair's Statement, Strategic Report and Notes to the Accounts of the 31 December 2024 Annual Report.
In addition, the Annual Report includes the Company's objectives, policies and processes for managing its capital; its financial risk management objectives; details of its financial instruments; and its exposures to credit risk and liquidity risk.
The Company has considerable financial resources together with investments and income generated therefrom across a variety of industries and sectors. As a consequence, the Directors believe that the Company is well placed to manage its business risks successfully.
The Directors have reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the annual financial statements.
The Half-Yearly Financial Report has not been audited nor reviewed by the auditors.
On behalf of the Board
Michael Gray Chair
26 September 2025
28 Foresight Enterprise VCT plc Unaudited Half-Yearly Financial Report 30 June 2025
29 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
For the six months ended 30 June 2025
| Six months ended 30 June 2025 (Unaudited) |
Six months ended 30 June 2024 (Unaudited) |
Year ended 31 December 2024 (Audited) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
|
| Realised gains on investments | — | 6,699 | 6,699 | — | 25,300 | 25,300 | — | 28,500 | 28,500 |
| Investment holding losses | — | (5,780) | (5,780) | — | (13,044) | (13,044) | — | (14,006) | (14,006) |
| Income | 2,078 | — | 2,078 | 1,750 | — | 1,750 | 3,249 | — | 3,249 |
| Investment management fees | (454) | (1,681) | (2,135) | (434) | (2,614) | (3,048) | (888) | (4,629) | (5,517) |
| Other expenses | (367) | — | (367) | (420) | — | (420) | (817) | — | (817) |
| Return/(loss) on ordinary activities before taxation |
1,257 | (762) | 495 | 896 | 9,642 | 10,538 | 1,544 | 9,865 | 11,409 |
| Taxation | (307) | 307 | — | (183) | 183 | — | (345) | 345 | — |
| Return/(loss) on ordinary activities after taxation |
950 | (455) | 495 | 713 | 9,825 | 10,538 | 1,199 | 10,210 | 11,409 |
| Return/(loss) per share | 0.3p | (0.1p) | 0.2p | 0.3p | 3.6p | 3.9p | 0.4p | 3.8p | 4.2p |
The total columns of this statement are the profit and loss account of the Company and the revenue and capital columns represent supplementary information.
All revenue and capital items in the above Statement of Comprehensive Income are derived from continuing operations. No operations were acquired or discontinued in the period.
The Company has no recognised gains or losses other than those shown above, therefore no separate statement of total recognised gains and losses has been presented.
The Company has only one class of business and one reportable segment, the results of which are set out in the Statement of Comprehensive Income and Balance Sheet.
There are no potentially dilutive capital instruments in issue and, therefore, no diluted earnings per share figures are relevant. The basic and diluted earnings per share are, therefore, identical.
Unaudited Half-Yearly Financial Report 30 June 2025
For the six months ended 30 June 2025
| Share | Capital | ||||||
|---|---|---|---|---|---|---|---|
| Called-up share capital £'000 |
premium account £'000 |
redemption reserve £'000 |
Distributable reserve1 £'000 |
Capital reserve1 £'000 |
Revaluation reserve £'000 |
Total £'000 |
|
| As at 1 January 2025 | 2,988 | 32,659 | 164 | 98,440 | (6,831) | 35,424 | 162,844 |
| Share issues in the period2 | 203 | 11,096 | — | — | — | — | 11,299 |
| Expenses in relation to share issues3 | — | (392) | — | — | — | — | (392) |
| Repurchase of shares | (47) | — | 47 | (2,299) | — | — | (2,299) |
| Realised gains on disposal of investments | — | — | — | — | 6,699 | — | 6,699 |
| Investment holding losses | — | — | — | — | — | (5,780) | (5,780) |
| Dividends paid | — | — | — | (9,812) | — | — | (9,812) |
| Management fees charged to capital | — | — | — | — | (1,681) | — | (1,681) |
| Revenue return for the period before taxation | — | — | — | 1,257 | — | — | 1,257 |
| Taxation for the period | — | — | — | (307) | 307 | — | — |
| As at 30 June 2025 | 3,144 | 43,363 | 211 | 87,279 | (1,506) | 29,644 | 162,135 |
Distributable reserve accounts at 30 June 2025 total £85,773,000 (31 December 2024: £91,609,000). Share premium cancelled in the prior year included amounts arising on share allotments less than three years old, which are protected capital under VCT legislation. Amounts available for distribution at 30 June 2025 are therefore £35,837,000 (31 December 2024: £41,673,000). The remaining cancelled share premium will become distributable under VCT regulations on the third anniversary of the share allotment on which it arose.
Includes the dividend reinvestment scheme.
Includes trail commission for prior years' fundraising.
31 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
| Registered number: 03506579 | As at 30 June 2025 (Unaudited) £'000 |
As at 30 June 2024 (Unaudited) £'000 |
As at 31 December 2024 (Audited) £'000 |
|---|---|---|---|
| Fixed assets | |||
| Investments held at fair value through profit or loss | 107,677 | 102,729 | 109,110 |
| Current assets | |||
| Debtors | 2,707 | 5,418 | 3,206 |
| Cash and cash equivalents | 52,642 | 64,515 | 50,859 |
| Total current assets | 55,349 | 69,933 | 54,065 |
| Creditors | |||
| Amounts falling due within one year | (891) | (1,591) | (331) |
| Net current assets | 54,458 | 68,342 | 53,734 |
| Net assets | 162,135 | 171,071 | 162,844 |
| Capital and reserves | |||
| Called-up share capital | 3,144 | 2,650 | 2,988 |
| Share premium account | 43,363 | 113,347 | 32,659 |
| Capital redemption reserve | 211 | 767 | 164 |
| Distributable reserve | 87,279 | 26,099 | 98,440 |
| Capital reserve | (1,506) | (8,178) | (6,831) |
| Revaluation reserve | 29,644 | 36,386 | 35,424 |
| Equity Shareholders' funds | 162,135 | 171,071 | 162,844 |
| Net Asset Value per share | 51.6p | 64.5p | 54.5p |
32 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
For the six months ended 30 June 2025
| Six months | Six months | ||
|---|---|---|---|
| ended | ended | Year ended | |
| 30 June 2025 |
30 June 2024 |
31 December 2024 |
|
| (Unaudited) | (Unaudited) | (Audited) | |
| £'000 | £'000 | £'000 | |
| Cash flow from operating activities | |||
| Loan interest received from investments | 663 | 401 | 932 |
| Dividends received from investments | 31 | 165 | 165 |
| Deposit and similar interest received | 1,190 | 979 | 2,174 |
| Investment management fees paid | (2,702) | (1,747) | (3,483) |
| Performance incentive fee paid | — | (1,115) | (3,079) |
| Secretarial fees paid | (159) | (101) | (207) |
| Other cash payments | (356) | (240) | (591) |
| Net cash outflow from operating activities | (1,333) | (1,658) | (4,089) |
| Cash flow from investing activities | |||
| Purchase of investments | (6,307) | (8,969) | (14,444) |
| Proceeds on sale of investments | 8,888 | 34,486 | 34,611 |
| Proceeds on deferred consideration | 1,361 | 1,057 | 4,257 |
| Net cash inflow from investing activities | 3,942 | 26,574 | 24,424 |
| Cash flow from financing activities | |||
| Proceeds of fundraising | 9,811 | 9,182 | 28,787 |
| Expenses of fundraising | (285) | (535) | (856) |
| Repurchase of own shares | (1,845) | (5,432) | (9,418) |
| Equity dividends paid | (8,507) | (11,459) | (35,832) |
| Net cash outflow from financing activities | (826) | (8,244) | (17,319) |
| Net inflow of cash in the period | 1,783 | 16,672 | 3,016 |
| Reconciliation of net cash flow to movement in net funds | |||
| Increase in cash and cash equivalents for the period | 1,783 | 16,672 | 3,016 |
| Net cash and cash equivalents at start of period | 50,859 | 47,843 | 47,843 |
| Net cash and cash equivalents at end of period | 52,642 | 64,515 | 50,859 |
Unaudited Half-Yearly Financial Report 30 June 2025
For the six months ended 30 June 2025
The Unaudited Half-Yearly Financial Report has been prepared on the basis of the accounting policies set out in the statutory accounts of the Company for the year ended 31 December 2024. Unquoted investments have been valued in accordance with IPEV Valuation Guidelines.
These are not statutory accounts in accordance with S436 of the Companies Act 2006 and the financial information for the six months ended 30 June 2025 and 30 June 2024 has been neither audited nor formally reviewed. Statutory accounts in respect of the year ended 31 December 2024 have been audited and reported on by the Company's auditors and delivered to the registrar of Companies and included the report of the auditors which was unqualified and did not contain a statement under S498(2) or S498(3) of the Companies Act 2006. No statutory accounts in respect of any period after 31 December 2024 have been reported on by the Company's auditors.
Copies of the Unaudited Half-Yearly Financial Report will be sent to Shareholders via their chosen method and will be available for inspection at the Registered Office of the Company at The Shard, 32 London Bridge Street, London SE1 9SG.
The Net Asset Value per share is based on net assets at the end of the period and on the number of shares in issue at the date.
| Net assets | Number of shares in issue |
|
|---|---|---|
| 30 June 2025 | £162,135,000 | 314,372,565 |
| 30 June 2024 | £171,071,000 | 265,024,186 |
| 31 December 2024 | £162,844,000 | 298,828,254 |
The weighted average number of shares used to calculate the respective returns are shown in the table below.
| Shares | |
|---|---|
| Six months ended 30 June 2025 | 314,923,965 |
| Six months ended 30 June 2024 | 271,618,784 |
| Year ended 31 December 2024 | 271,803,550 |
Earnings for the period should not be taken as a guide to the results for the full year.
| Six months ended 30 June 2025 £'000 |
Six months ended 30 June 2024 £'000 |
Year ended 31 December 2024 £'000 |
|
|---|---|---|---|
| Deposit and similar interest received | 1,190 | 979 | 2,174 |
| Loan stock interest | 857 | 606 | 910 |
| Dividends receivable | 31 | 165 | 165 |
| Total income | 2,078 | 1,750 | 3,249 |
34 Foresight Enterprise VCT plc
Unaudited Half-Yearly Financial Report 30 June 2025
For the six months ended 30 June 2025
| £'000 | |
|---|---|
| Book cost as at 1 January 2025 | 76,774 |
| Investment holding gains | 32,336 |
| Valuation at 1 January 2025 | 109,110 |
| Movements in the period: | |
| Purchases | 6,307 |
| Disposal proceeds1 | (8,888) |
| Realised gains2 | 5,338 |
| Investment holding losses3 | (4,190) |
| Valuation at 30 June 2025 | 107,677 |
| Book cost at 30 June 2025 | 79,531 |
| Investment holding gains | 28,146 |
| Valuation at 30 June 2025 | 107,677 |
The Company received £8,888,000 from the disposal of investments and a loan repayment during the period. The book cost of the investments and the repaid loan was £3,550,000. These investments have been revalued over time and until they were sold, any unrealised gains or losses were included in the fair value of the investments.
Realised gains in the Statement of Comprehensive Income include deferred consideration receipts from Datapath Group Limited (£583,000), Specac International Limited (£475,000), Callen-Lenz Associates Limited (£300,000) and Mologic Ltd (£3,000).
Investment holding losses in the Statement of Comprehensive Income include the deferred consideration debtor decrease of £1,590,000. The debtor movement reflects receipts from Datapath Group Limited (£583,000), Specac International Limited (£475,000), Callen-Lenz Associates Limited (£300,000) and Mologic Ltd (£3,000), and a provision made against the balance potentially due from Specac International Limited (£229,000).
In order to incentivise the Manager to generate enhanced returns for Shareholders, the Manager is entitled to a performance incentive fee, designated a share-based payment due to its nature. This fee is equal to 15% of dividends paid to Shareholders, subject to the total return (Net Asset Value plus cumulative dividends paid per share on or after 11 January 2011) exceeding 100p ("High Watermark"), both immediately before and after the performance incentive fee is paid. After each distribution is made to Shareholders where a performance incentive is paid, the High Watermark required to be achieved to trigger a further performance incentive fee will be amended to take account of the dividend paid.
The High Watermark as at 16 May 2025, the date that the 3.1p special dividend was paid, was 116.8p and the total return was 117.5p. As a result of the total return being above the High Watermark, a £318,000 performance incentive fee was accrued during the period (31 December 2024: £3,079,000) with respect to the May 2025 dividend. Following the payment of the May 2025 dividend, the High Watermark as at 30 June 2025 was 117.4p (31 December 2024: 116.8p) and the total return was 117.7p (31 December 2024: 117.5p). At 30 June 2025, the Company has accrued an amount of £318,000 in relation to performance incentive fees (31 December 2024: £nil).
Foresight Group LLP advises the Company on investments under an agreement dated 30 July 2004. During the period, Foresight Group LLP earned fees of £1,817,000 (30 June 2024: £1,736,000; 31 December 2024: £3,553,000). A performance incentive fee of £nil (30 June 2024: £1,115,000; 31 December 2024: £3,079,000) was paid in the period with an additional provision of £318,000 (30 June 2024: £1,312,000; 31 December 2024: £nil) recognised as at the period end.
Foresight Group LLP is the Company Secretary and received accounting and company secretarial services fees of £104,000 during the period (30 June 2024: £101,000; 31 December 2024: £207,000).
At 30 June 2025, the amount due to Foresight Group LLP was £nil (30 June 2024: (£46,000); 31 December 2024: £34,000).
Unaudited Half-Yearly Financial Report 30 June 2025
| VCT | A Venture Capital Trust as defined in the Income Tax Act 2007. | Shares bought back in | The total number of shares which were bought back in the period, |
|---|---|---|---|
| Net Asset Value or NAV | The Net Asset Value ("NAV") is the amount by which total assets exceed total liabilities, i.e. the difference between what the Company owns and what it owes. It is equal to Shareholders' equity, sometimes referred to as Shareholders' funds. |
the period Average discount on buybacks |
being 4,698,159 (31 December 2024: 16,473,505). The average of the percentage by which the buyback price is lower than the Net Asset Value per share at the point of the buyback. |
| Net Asset Value per share Net Asset Value expressed as an amount per share. or NAV per share |
Ongoing charges ratio | The sum of expenditure incurred in the ordinary course of business after adding back the performance incentive provision to total expenses in the period being £2.1 million (31 December 2024: |
|
| NAV Total Return per share |
The NAV per share at the end of the period of 51.6p (31 December 2024: 54.5p) plus all dividends paid per share in the period being 3.1p (31 December 2024: 15.4p). As such, NAV Total Return per share was 54.7p (31 December 2024: 69.9p). |
£4.3 million) expressed as a percentage of the Net Asset Value at the end of the period after adding back special dividends paid in the period to the period‑end net assets being £171.9 million (31 December 2024: £191.0 million). Expenses have been annualised for the purpose of this calculation. |
|
| Movement in NAV Total Return per share |
This is the percentage change from the NAV per share at the start of the period being 54.5p (31 December 2024: 65.6p) to the NAV Total Return per share being 54.7p (31 December 2024: 69.9p). Therefore, the movement in NAV Total Return in the period is 0.4% (31 December 2024: 6.6%). |
Qualifying Company | A company satisfying certain conditions under the VCT legislation. The conditions are detailed but include that the company must be unquoted (companies listed on AIM or AQUIS can qualify), have a permanent establishment in the UK, apply the money raised for the purposes of growth and development of a qualifying trade within a certain time period and not be controlled by another company. There are additional restrictions relating to the size and stage of the company to focus investment into earlier‑stage businesses, as well as maximum investment limits (certain of such restrictions and limits being more flexible for "knowledge intensive" companies). VCT |
| Discount to NAV | A discount to NAV is the percentage by which the mid-market share price of the Company of 48.8p (31 December 2024: 50.5p) is lower than the Net Asset Value per share as at the period end of 51.6p (31 December 2024: 54.5p). This gives a discount to NAV of 5.4% (31 December 2024: 7.3%). |
||
| Dividends paid in the period |
The total dividends per share paid in the period of 3.1p (31 December 2024: 15.4p). |
funds cannot be used by a Qualifying Company to acquire shares in another company or a trade. |
|
| Dividend yield The sum of dividends paid during the period of 3.1p (31 December 2024: 15.4p) expressed as a percentage of the mid‑market share price at the period end date of 48.8p (31 December 2024: 50.5p). This gives a dividend yield of 6.4% (31 December 2024: 30.5%). |
Qualifying investment | An investment which consists of shares or securities first issued to the VCT (and held by it ever since) by a Qualifying Company and satisfying certain conditions under the VCT legislation. |
|
| Manager | Foresight Group LLP. | ||
| Foresight | Foresight Group Holdings Limited and its subsidiary companies and undertakings (which includes the Manager). |
Unaudited Half-Yearly Financial Report 30 June 2025

Fraudsters use persuasive and high-pressure tactics to lure investors into scams.
They may offer to sell you shares that turn out to be worthless or non-existent, or to buy shares at an inflated price in return for an upfront payment.
While high profits are promised, if you buy or sell shares in this way you will probably lose your money.
If you are approached by fraudsters please tell the FCA using the share fraud reporting form at www.fca.org.uk/scams, where you can find out more about investment scams.
You can also call the FCA Consumer Helpline on 0800 111 6768.
If you have already paid money to share fraudsters you should contact Action Fraud on 0300 123 2040.
In association with

Unaudited Half-Yearly Financial Report 30 June 2025
03506579
Michael Gray (Chair) Kavita Patel (Deputy Chair) Gaynor Coley Ian Harris
The Shard 32 London Bridge Street London SE1 9SG
Foresight Group LLP
The Shard 32 London Bridge Street London SE1 9SG
20 Castle Terrace Edinburgh EH1 2DB
No. 1 Colmore Square Birmingham B4 6AA
and
60 Gracechurch Street London EC3V 0HR
The Pavilions Bridgwater Road Bristol BS99 6ZZ
Level 12, Ropemaker Place 25 Ropemaker Street London EC2Y 9LY
Lloyds Bank plc 25 Gresham Street London EC2V 7HN
Unaudited Half-Yearly Financial Report 30 June 2025
We respect your privacy and are committed to protecting your personal data. If you would like to find out more about the measures the Manager takes in processing your personal information, please refer to the privacy policy, which can be found at www.foresightgroup.eu/privacy-policy.
Share buybacks are timed to avoid the Company's closed periods. Buybacks will generally take place, subject to demand, during the following times of the year:
The Company's shares are listed on the London Stock Exchange. Share price information is available on Foresight Group LLP's website and can also be obtained from many financial websites.
The Company's shares can be bought and sold in the same way as any other quoted company on the London Stock Exchange via a stockbroker. The primary market maker for Foresight Enterprise VCT plc is Panmure Liberum Limited.
You can contact Panmure Liberum by phone on 0207 886 2716 or 0207 886 2717.
Investment in VCTs should be seen as a long-term investment and Shareholders selling their shares within five years of original subscription may lose any tax reliefs claimed. Investors who are in any doubt about selling their shares should consult their independent financial adviser.
Please contact the Manager if you or your adviser have any questions about this process.
Foresight Enterprise VCT plc currently conducts its affairs so that its shares can be recommended by IFAs to ordinary retail investors in accordance with the FCA's rules in relation to non-mainstream pooled investment products and intends to continue to do so for the foreseeable future.
The shares are excluded from the FCA's restrictions which apply to non-mainstream pooled investment products because they are shares in a VCT.
Past performance is not necessarily a guide to future performance. Stock markets and currency movements may cause the value of investments and the income from them to fall as well as rise and investors may not get back the amount they originally invested. Where investments are made in unquoted securities and smaller companies, their potential volatility increases the risk to the value of, and the income from, the investment.
Unaudited Half-Yearly Financial Report 30 June 2025
Foresight Enterprise VCT plc is a Venture Capital Trust aiming to provide investors with attractive returns from a portfolio of investments in fast-growing, unquoted UK companies.
For details on the Company's investment policy please refer to the Strategic Report in the 2024 Annual Report.
The Board and Manager are always keen to hear from investors. If you have any feedback about the service you receive or any queries relating to Foresight Enterprise VCT plc, please contact the Investor Relations team:
Annual and Half-Yearly Reports, as well as quarterly factsheets and information on new investments, can be viewed online.
As part of the Manager's investor communications policy, investor forums are held throughout the year. Shareholders can also arrange a mutually convenient time to meet the Manager's investment team. Please contact Investor Relations if you are interested.
All cash dividends will be credited to your nominated bank/ building society account. Your options are:
| Annual results to 31 December 2025 | April 2026 |
|---|---|
| Annual General Meeting | June 2026 |
| Half-Yearly results to 30 June 2026 | September 2026 |
Investors can manage their shareholding online using Investor Centre, Computershare's secure website.
Shareholders just require their Shareholder Reference Number ("SRN"), which can be found on any communications previously received from Computershare, to access the following:
Holding enquiry Balances | Values history | Payments | Reinvestments
Payments enquiry Dividends | Other payment types
Address change Change registered address to which all communications are sent
Bank details update Please ensure bank details are up to date in order to receive your dividends
Outstanding payments Reissue payments using our online replacement service
Downloadable forms Dividend mandates | Stock transfer | Dividend reinvestment | Change of address
Alternatively, you can contact Computershare by phone on 0370 703 6388
Unaudited Half-Yearly Financial Report 30 June 2025


This report is printed on Nautilus which is made from FSC® recycled certified post-consumer waste pulp. The FSC® label on this report ensures responsible use of the world's forest resources. Printed sustainably in the UK by Pureprint, a CarbonNeutral® company with FSC® chain of custody and an ISO 14001 certified environmental management system recycling 100% of all dry waste.

The Shard 32 London Bridge Street London SE1 9SG
foresightvct.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.